Transcatheter valves still make up one of the relatively few therapeutic
areas in med-tech that is both large and growing at a significant rate.
That does not mean that it's all downhill for Edwards Lifesciences (NYSE: EW ) , however, as the company continues to struggle to meet expectations in the U.S. and hold off Medtronic (NYSE: MDT )
in the marketplace. Good market positions in tissue valves and
critical care will help some, but the twin challenges of competing with
Medtronic and overcoming disappointment with the company's growth are
likely to still weigh on the stock.
Read more here:
Edwards Lifesciences Corp. Still Trying To Regain Footing
No comments:
Post a Comment